Acadia Pharmaceuticals Inc
ACAD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001070494
In the last 90 days, Acadia Pharmaceuticals Inc insiders filed 0 open-market purchases and 2 sales; 353 institutions reported holding it in 13F filings for Q2 2026, worth $4.27B in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Acadia Pharmaceuticals Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $1.02M in total
- Insiders trading
- 2
- Net value
- −$1.02M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Acadia Pharmaceuticals Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Schneyer Mark C. | EVP, CHIEF FINANCIAL OFFICER | 67,828 | Aug 7, 2026 | 6 |
| Thompson Elizabeth H.Z. | EVP, Head of Research & Dev | 18,994 | Jul 31, 2026 | 3 |
| Kihara James | PRINCIPAL ACCOUNTING OFFICER | 13,088 | Jun 29, 2026 | 7 |
| Baker Julian | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Baker Felix | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Baker Bros. Advisors LP | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| 667, L.P. | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 39,384,587Indirect | Jun 2, 2026 | 1 |
| Harrigan Edmund | Director | 43,148 | Jun 1, 2026 | 1 |
| Brege Laura | Director | 23,202 | Jun 1, 2026 | 1 |
| Daly James M | Director | 12,148 | Jun 1, 2026 | 2 |
| Poole Jonathan | Director | 2,010 | Jun 1, 2026 | 2 |
| Garofalo Elizabeth A. | Director | 33,489 | Jun 1, 2026 | 1 |
| Ndu Adora | Director | 32,908 | Jun 1, 2026 | 1 |
| Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | 11,280 | Mar 26, 2026 | 3 |
| Owen Catherine E. | Chief Executive Officer | 14,803 | Mar 26, 2026 | 2 |
| Garner Thomas | EVP, Chief Commercial Officer | – | Mar 10, 2026 | 1 |
| Soland Daniel B | Director | 44,041 | Jun 2, 2025 | 0 |
| Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | 62,105 | Nov 19, 2024 | 0 |
| Davis Stephen | CEO | 186,555 | Aug 20, 2024 | 0 |
| Kim Austin D. | EVP,General Counsel, Secretary | 46,901 | Jan 9, 2024 | 0 |
| Williamson Douglas J | Executive VP, Research & Dev | – | Feb 13, 2023 | 0 |
| Stankovic Srdjan R. | President | 61,234 | Nov 22, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022 (view filing) | Apr 8 | 3 days | Kihara JamesPrincipal Accounting Officer | SSale | −1.02K | $27.05 | −$27.7K | −29.6%2.43K after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Kihara JamesPrincipal Accounting Officer | SSale | −359 | $23.80 | −$8.54K | −42.7%481 after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Teehan BrendanEVP, COO, Head of Commercial | SSale | −472 | $23.80 | −$11.2K | −16.3%2.42K after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Schneyer Mark C.Chief Financial Officer | SSale | −553 | $23.80 | −$13.2K | −20.8%2.10K after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Kim Austin D.EVP & General Counsel | SSale | −782 | $23.80 | −$18.6K | −5.1%14.6K after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Stankovic Srdjan R.President | SSale | −1.50K | $23.80 | −$35.7K | −3.0%48.4K after | |
| Feb 25, 2022 (view filing) | Feb 23 | 2 days | Davis StephenCEO | SSale | −3.93K | $23.80 | −$93.5K | −5.6%65.7K after | |
| Jan 10, 2022 (view filing) | Jan 6 | 4 days | Teehan BrendanEVP, COO, Head of Commercial | SSale | −538 | $23.05 | −$12.4K | −23.1%1.79K after | |
| Jan 10, 2022 (view filing) | Jan 6 | 4 days | Kim Austin D.EVP & General Counsel | SSale | −574 | $23.05 | −$13.2K | −4.2%13.2K after | |
| Jan 10, 2022 (view filing) | Jan 6 | 4 days | Stankovic Srdjan R.President | SSale | −1.94K | $23.05 | −$44.6K | −4.1%45.0K after | |
| Jan 10, 2022 (view filing) | Jan 6 | 4 days | Davis StephenCEO | SSale | −3.72K | $23.05 | −$85.7K | −6.0%58.7K after | |
| Nov 23, 2021 (view filing) | Nov 22 | 1 day | Stankovic Srdjan R.President | SSale | −2.80K | $19.01 | −$53.3K | −6.3%41.5K after | |
| Oct 19, 2021 (view filing) | Oct 18 | 1 day | Stankovic Srdjan R.President | SSale | −1.34K | $17.41 | −$23.3K | −3.4%38.1K after | |
| Oct 19, 2021 (view filing) | Oct 18 | 1 day | Davis StephenCEO | SSale | −2.96K | $17.41 | −$51.6K | −5.3%52.9K after |